Pulmonary Vascular Resistance Is Associated With Brachial-Ankle Pulse-Wave Velocity and Adverse Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction |
| |
Authors: | Takamitsu Nakamura Manabu Uematsu Juntaro Deyama Yosuke Watanabe Kazuto Nakamura Tsuyoshi Kobayashi Yukio Saito Daisuke Fujioka Ken-ichi Kawabata Jun-ei Obata Kiyotaka Kugiyama |
| |
Affiliation: | Department of Internal Medicine II, Faculty of Medicine, University of Yamanashi, Chuo, Japan |
| |
Abstract: | BackgroundThe precise mechanisms underlying the high prevalence of pulmonary hypertension (PH) with increased pulmonary vascular resistance (PVR) in heart failure with preserved ejection fraction (HFpEF) remain largely unknown. Measurements of brachial-ankle pulse wave velocity (baPWV) have been shown to be useful for risk assessment in HF patients. Thus, this study sought to define the association of PVR with baPWV and clinical outcomes in HFpEF.Methods and ResultsPatients with HFpEF (n = 198) had measurements of baPWV and PVR by right heart catheterization, and were prospectively followed-up for <96 months or until the occurrence of a composite of all-cause death, hospitalization with worsening HF, and nonfatal acute coronary syndrome.ResultsMultivariate logistic analysis showed that baPWV was independently associated with PH with increased PVR (P < .001). During the follow-up period, 46 clinical events occurred. Multivariate Cox proportional hazards analysis showed that PH with increased PVR was a significant predictor of adverse outcomes after adjustment for conventional risk factors (HR 1.96, 95% CI 1.03–3.76, P = .04).ConclusionsPH with increased PVR was associated with increased baPWV and adverse clinical outcomes in HFpEF. Thus, increased arterial stiffness may contribute to increased risk predictability of PVR for patients with HFpEF. |
| |
Keywords: | Reprint requests: Takamitsu Nakamura, MD, PhD, Department of Internal Medicine II, University of Yamanashi, Faculty of Medicine 1110 Shimokato, Chuo, 409-3898 Japan. Tel: +81-55-273-9590, Fax: +81-55-273-6749. HFpEF PVR baPWV clinical outcomes |
本文献已被 ScienceDirect 等数据库收录! |
|